Docstoc

Aarkstore Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012

Document Sample
Aarkstore Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012 Powered By Docstoc
					Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H1
2012, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic
pipeline. This report provides information on the therapeutic development for Chronic
Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players involved in the therapeutic
development for Chronic Obstructive Pulmonary Disease (COPD). Chronic Obstructive
Pulmonary Disease (COPD) Pipeline Review, H1 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC
filings, investor presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for Chronic Obstructive Pulmonary Disease
(COPD).
A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development
by companies and universities/research institutes based on information derived from company
and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till
registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Chronic Obstructive Pulmonary Disease (COPD) pipeline on the basis of route
of administration and molecule type.
Profiles of late-stage pipeline products featuring sections on product description, mechanism of
action and research & development progress.
Key discontinued pipeline projects.
Latest news and deals relating to the products.

Reasons to buy

Identify and understand important and diverse types of therapeutics under development for
Chronic Obstructive Pulmonary Disease (COPD).
Identify emerging players with potentially strong product portfolio and design effective counter-
strategies to gain competitive advantage.
Plan mergers and acquisitions effectively by identifying players with the most promising
pipeline.
Devise corrective measures for pipeline projects by understanding Chronic Obstructive
Pulmonary Disease (COPD) pipeline depth and focus of Chronic Obstructive Pulmonary Disease
(COPD) therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and scope.
Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline.



    RSS FEED

For more information, please visit :-

http://www.aarkstore.com/reports/Chronic-Obstructive-Pulmonary-Disease-COPD-Pipeline-
Review-H1-2012-191673.html

Marketing Team

Aarkstore Enterprise

Phone:08149852585

Email:enquiry@aarkstore.com

URL:www.aarkstore.com

http://twitter.com/aarkstoredotcom

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstoreenterprise

More Related Reports :-

Migraine – Pipeline Review, H1 2012
Colorectal Cancer – Pipeline Review, H1 2012
HIV / AIDS – Pipeline Review, H1 2012
Prostate Cancer – Pipeline Review, H1 2012
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H1 2012
Head And Neck Cancer – Pipeline Review, H1 2012
Gastric Cancer – Pipeline Review, H1 2012
Type 2 Diabetes – Pipeline Review, H1 2012
Non-Hodgkin Lymphoma – Pipeline Review, H1 2012
Asthma – Pipeline Review, H1 2012

				
DOCUMENT INFO
Description: Aarkstore announce a new report " Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012" through its vast collection of market research report